causal
Biotech follows the capital cycle
The history of biotech is closely tied to the capital cycle, and Argenx's advantage lies in attracting long-term investors who will support the company through progress without forcing it to sacrifice its pipeline.
causalpending
Speaker
JuliaEvidence Quote
“the ability to attract long-term investors who are interested to supporting the company over the long term”
Created: 11/17/2026, 3:39:21 AM
Your notes
Loading notes...